{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:58:05Z","timestamp":1781056685239,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81974482"],"award-info":[{"award-number":["81974482"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian province","award":["2021Y9191"],"award-info":[{"award-number":["2021Y9191"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J011238"],"award-info":[{"award-number":["2023J011238"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00405-026-10128-9","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T20:36:32Z","timestamp":1774730192000},"page":"3963-3977","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HSPA5 overexpression predicts poor prognosis and drives radioresistance and metastasis in nasopharyngeal carcinoma"],"prefix":"10.1007","volume":"283","author":[{"given":"Huo-Cong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Dong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9105-2129","authenticated-orcid":false,"given":"Jian-Ru","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"10128_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. Lancet 394:64\u201380","journal-title":"Lancet"},{"key":"10128_CR2","doi-asserted-by":"publisher","first-page":"110613","DOI":"10.1016\/j.radonc.2024.110613","volume":"202","author":"B Chen","year":"2025","unstructured":"Chen B, Zhan Z, Xu Y et al (2025) Long-term trends in the burden of nasopharyngeal carcinoma in China: A comprehensive analysis from 1990 to 2021 and projections to 2030 based on the global burden of disease study 2021. Radiother Oncol 202:110613","journal-title":"Radiother Oncol"},{"key":"10128_CR3","doi-asserted-by":"publisher","first-page":"102613","DOI":"10.1016\/j.arr.2024.102613","volume":"104","author":"Q Liu","year":"2025","unstructured":"Liu Q, Wang H, Chen Z et al (2025) Global, regional, and national epidemiology of nasopharyngeal carcinoma in middle-aged and elderly patients from 1990 to 2021. Ageing Res Rev 104:102613","journal-title":"Ageing Res Rev"},{"key":"10128_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","volume":"18","author":"KCW Wong","year":"2021","unstructured":"Wong KCW, Hui EP, Lo KW et al (2021) Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol 18:679\u2013695","journal-title":"Nat Rev Clin Oncol"},{"key":"10128_CR5","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/cac2.12218","volume":"41","author":"LL Tang","year":"2021","unstructured":"Tang LL, Chen YP, Chen CB et al (2021) The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma. Cancer Commun (Lond) 41:1195\u20131227","journal-title":"Cancer Commun (Lond)"},{"key":"10128_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jama.2022.21036","volume":"329","author":"R Guo","year":"2023","unstructured":"Guo R, Tang LL, Ma J (2023) Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy and Survival of Patients With Low-Risk Nasopharyngeal Carcinoma-Reply. JAMA 329:261\u2013262","journal-title":"JAMA"},{"key":"10128_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12885-019-5774-2","volume":"19","author":"F Liu","year":"2019","unstructured":"Liu F, Luo T, Jin T et al (2019) Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study. BMC Cancer 19:554","journal-title":"BMC Cancer"},{"key":"10128_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.radonc.2020.12.035","volume":"156","author":"Q Guo","year":"2021","unstructured":"Guo Q, Zheng Y, Lin J et al (2021) Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: A prospective observation series. Radiother Oncol 156:251\u2013257","journal-title":"Radiother Oncol"},{"key":"10128_CR9","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.ctrv.2019.101890","volume":"79","author":"AWM Lee","year":"2019","unstructured":"Lee AWM, Ng WT, Chan JYW et al (2019) Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev 79:101890","journal-title":"Cancer Treat Rev"},{"key":"10128_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10555-024-10176-9","volume":"43","author":"ZY Su","year":"2024","unstructured":"Su ZY, Siak PY, Lwin YY, Cheah SC (2024) Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev 43:919\u2013939","journal-title":"Cancer Metastasis Rev"},{"key":"10128_CR11","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/OTT.S188148","volume":"12","author":"F Perri","year":"2019","unstructured":"Perri F, Della Vittoria Scarpati G, Caponigro F et al (2019) Management of recurrent nasopharyngeal carcinoma: current perspectives. Onco Targets Ther 12:1583\u20131591","journal-title":"Onco Targets Ther"},{"key":"10128_CR12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12967-023-04673-8","volume":"21","author":"PY Siak","year":"2023","unstructured":"Siak PY, Heng WS, Teoh SSH, Lwin YY, Cheah SC (2023) Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. J Transl Med 21:786","journal-title":"J Transl Med"},{"key":"10128_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0968-0004(01)01908-9","volume":"26","author":"AS Lee","year":"2001","unstructured":"Lee AS (2001) The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci 26:504\u2013510","journal-title":"Trends Biochem Sci"},{"key":"10128_CR14","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1158\/0008-5472.CAN-06-4594","volume":"67","author":"Y Fu","year":"2007","unstructured":"Fu Y, Li J, Lee AS (2007) GRP78\/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res 67:3734\u20133740","journal-title":"Cancer Res"},{"key":"10128_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1158\/0008-5472.CAN-07-2950","volume":"68","author":"D Dong","year":"2008","unstructured":"Dong D, Ni M, Li J et al (2008) Critical role of the stress chaperone GRP78\/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res 68:498\u2013505","journal-title":"Cancer Res"},{"key":"10128_CR16","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1158\/0008-5472.CAN-07-0325","volume":"67","author":"AS Lee","year":"2007","unstructured":"Lee AS (2007) GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 67:3496\u20133499","journal-title":"Cancer Res"},{"key":"10128_CR17","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jconrel.2020.10.055","volume":"328","author":"M Farshbaf","year":"2020","unstructured":"Farshbaf M, Khosroushahi AY, Mojarad-Jabali S, Zarebkohan A, Valizadeh H, Walker PR (2020) Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer. J Control Release 328:932\u2013941","journal-title":"J Control Release"},{"key":"10128_CR18","doi-asserted-by":"publisher","first-page":"13694","DOI":"10.1074\/jbc.M511694200","volume":"281","author":"UK Misra","year":"2006","unstructured":"Misra UK, Deedwania R, Pizzo SV (2006) Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J Biol Chem 281:13694\u201313707","journal-title":"J Biol Chem"},{"key":"10128_CR19","doi-asserted-by":"publisher","first-page":"7849","DOI":"10.1158\/0008-5472.CAN-06-1660","volume":"66","author":"E Lee","year":"2006","unstructured":"Lee E, Nichols P, Spicer D, Groshen S, Yu MC, Lee AS (2006) GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Res 66:7849\u20137853","journal-title":"Cancer Res"},{"key":"10128_CR20","doi-asserted-by":"publisher","first-page":"101576","DOI":"10.1016\/j.tranon.2022.101576","volume":"27","author":"WM Huang","year":"2023","unstructured":"Huang WM, Li ZX, Wu YH et al (2023) m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis. Transl Oncol 27:101576","journal-title":"Transl Oncol"},{"key":"10128_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1600-0714.2007.00624.x","volume":"37","author":"R Kummoona","year":"2008","unstructured":"Kummoona R, Mohammad S\u00e1mi S, Al-Kapptan I, Al-Muala H (2008) Study of antiapoptotic gene of oral carcinoma by using Bcl-2 oncogene. J Oral Pathol Med 37:345\u2013351","journal-title":"J Oral Pathol Med"},{"key":"10128_CR22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.ijrobp.2008.12.015","volume":"75","author":"S Lin","year":"2009","unstructured":"Lin S, Pan J, Han L, Zhang X, Liao X, Lu JJ (2009) Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys 75:1071\u20131078","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10128_CR23","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","volume":"16","author":"M Al-Sarraf","year":"1998","unstructured":"Al-Sarraf M, LeBlanc M, Giri PG et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310\u20131317","journal-title":"J Clin Oncol"},{"key":"10128_CR24","doi-asserted-by":"publisher","first-page":"107716","DOI":"10.1016\/j.exer.2019.107716","volume":"186","author":"N Chen","year":"2019","unstructured":"Chen N, Hu Z, Yang Y, Han H, Lei H (2019) Inactive Cas9 blocks vitreous-induced expression of Mdm2 and proliferation and survival of retinal pigment epithelial cells. Exp Eye Res 186:107716","journal-title":"Exp Eye Res"},{"key":"10128_CR25","doi-asserted-by":"publisher","first-page":"114755","DOI":"10.1016\/j.yexcr.2025.114755","volume":"452","author":"H He","year":"2025","unstructured":"He H, Huang Z, Wen F, Ge N, Lin X, Pan J (2025) PSPC1 knockout promotes radiosensitivity, inhibits EMT, and metastasis of nasopharyngeal carcinoma cells. Exp Cell Res 452:114755","journal-title":"Exp Cell Res"},{"key":"10128_CR26","doi-asserted-by":"publisher","first-page":"769544","DOI":"10.3389\/fonc.2022.769544","volume":"12","author":"H He","year":"2022","unstructured":"He H, Lin K, Zou C et al (2022) Knockdown of Annexin A2 Enhances Radiosensitivity by Increasing G2\/M-Phase Arrest, Apoptosis and Activating the p38 MAPK-HSP27 Pathway in Nasopharyngeal Carcinoma. Front Oncol 12:769544","journal-title":"Front Oncol"},{"key":"10128_CR27","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1038\/s41388-018-0565-9","volume":"38","author":"J An","year":"2019","unstructured":"An J, Du Y, Fan X et al (2019) EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis. Oncogene 38:2123\u20132134","journal-title":"Oncogene"},{"key":"10128_CR28","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1634\/theoncologist.2017-0577","volume":"24","author":"L Chen","year":"2019","unstructured":"Chen L, Zhang Y, Lai SZ et al (2019) 10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma. Oncologist 24:e38\u2013e45","journal-title":"Oncologist"},{"key":"10128_CR29","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.xcrm.2024.101594","volume":"5","author":"W Jiang","year":"2024","unstructured":"Jiang W, Lv JW, Tang LL, Sun Y, Chen YP, Ma J (2024) Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma. Cell Rep Med 5:101594","journal-title":"Cell Rep Med"},{"key":"10128_CR30","first-page":"691","volume":"53","author":"B Cui","year":"2024","unstructured":"Cui B, Xu C, Xu Y, Chen A, Mao C, Chen Y (2024) [Causal relationship between ferroptosis-related gene HSPA5 and hepatocellular carcinoma: a study based on mendelian randomization and mediation analysis]. Zhejiang Da Xue Xue Bao Yi Xue Ban 53:691\u2013698","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10128_CR31","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1158\/0008-5472.CAN-10-3151","volume":"71","author":"D Dong","year":"2011","unstructured":"Dong D, Stapleton C, Luo B et al (2011) A critical role for GRP78\/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res 71:2848\u20132857","journal-title":"Cancer Res"},{"key":"10128_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12967-021-02786-6","volume":"19","author":"S Xia","year":"2021","unstructured":"Xia S, Duan W, Liu W, Zhang X, Wang Q (2021) GRP78 in lung cancer. J Transl Med 19:118","journal-title":"J Transl Med"},{"key":"10128_CR33","doi-asserted-by":"publisher","first-page":"e2406674","DOI":"10.1002\/advs.202406674","volume":"12","author":"S Wei","year":"2025","unstructured":"Wei S, Fan X, Li X et al (2025) Hypoxia Induced Lnc191 Upregulation Dictates the Progression of Esophageal Squamous Cell Carcinoma by Activating GRP78\/ERK Pathway. Adv Sci (Weinh) 12:e2406674","journal-title":"Adv Sci (Weinh)"},{"key":"10128_CR34","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41419-024-07040-7","volume":"15","author":"J Zhao","year":"2024","unstructured":"Zhao J, Kang M, Li H et al (2024) QRICH1 suppresses pediatric T-cell acute lymphoblastic leukemia by inhibiting GRP78. Cell Death Dis 15:646","journal-title":"Cell Death Dis"},{"key":"10128_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.lungcan.2018.06.005","volume":"122","author":"D Kwon","year":"2018","unstructured":"Kwon D, Koh J, Kim S et al (2018) Overexpression of endoplasmic reticulum stress-related proteins, XBP1s and GRP78, predicts poor prognosis in pulmonary adenocarcinoma. Lung Cancer 122:131\u2013137","journal-title":"Lung Cancer"},{"key":"10128_CR36","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3727\/096504017X14867268787969","volume":"25","author":"C Luo","year":"2017","unstructured":"Luo C, Qiu J (2017) miR-181a Inhibits Cervical Cancer Development via Downregulating GRP78. Oncol Res 25:1341\u20131348","journal-title":"Oncol Res"},{"key":"10128_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s13046-019-1413-7","volume":"38","author":"Y Chen","year":"2019","unstructured":"Chen Y, Mi Y, Zhang X et al (2019) Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK\/ATF4\/HSPA5 pathway in glioma cells. J Exp Clin Cancer Res 38:402","journal-title":"J Exp Clin Cancer Res"},{"key":"10128_CR38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s42003-020-01378-2","volume":"3","author":"W Huang","year":"2020","unstructured":"Huang W, Liao CC, Han Y et al (2020) Co-activation of Akt, Nrf2, and NF-\u03baB signals under UPR(ER) in torpid Myotis ricketti bats for survival. Commun Biol 3:658","journal-title":"Commun Biol"},{"key":"10128_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41419-019-1408-5","volume":"10","author":"P Dauer","year":"2019","unstructured":"Dauer P, Sharma NS, Gupta VK et al (2019) ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining stemness. Cell Death Dis 10:132","journal-title":"Cell Death Dis"},{"key":"10128_CR40","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.3892\/or.2017.6000","volume":"38","author":"X Qiu","year":"2017","unstructured":"Qiu X, Guan X, Liu W, Zhang Y (2017) DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer. Oncol Rep 38:3103\u20133113","journal-title":"Oncol Rep"},{"key":"10128_CR41","doi-asserted-by":"publisher","first-page":"156162","DOI":"10.1016\/j.phymed.2024.156162","volume":"135","author":"J Hu","year":"2024","unstructured":"Hu J, Chen NN, Li LG et al (2024) Cepharanthine-mediated endoplasmic reticulum stress inhibits Notch1 via binding GRP78 for suppressing hepatocellular carcinoma metastasis. Phytomedicine 135:156162","journal-title":"Phytomedicine"},{"key":"10128_CR42","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.3390\/ijms24065144","volume":"24","author":"Q Wang","year":"2023","unstructured":"Wang Q, Ke S, Liu Z, Shao H, He M, Guo J (2023) HSPA5 promotes the proliferation, metastasis and regulates ferroptosis of bladder cancer. Int J Mol Sci 24:5144","journal-title":"Int J Mol Sci"},{"key":"10128_CR43","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/onc.2015.214","volume":"35","author":"YW Chang","year":"2016","unstructured":"Chang YW, Tseng CF, Wang MY et al (2016) Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer. Oncogene 35:1517\u20131528","journal-title":"Oncogene"},{"key":"10128_CR44","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.oraloncology.2012.02.017","volume":"48","author":"AW Lee","year":"2012","unstructured":"Lee AW, Fee WE Jr., Ng WT, Chan LK (2012) Nasopharyngeal carcinoma: salvage of local recurrence. Oral Oncol 48:768\u2013774","journal-title":"Oral Oncol"},{"key":"10128_CR45","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1200\/JCO.22.02328","volume":"41","author":"E Yilmaz","year":"2023","unstructured":"Yilmaz E, Ismaila N, Bauman JE et al (2023) Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline. J Clin Oncol 41:1132\u20131146","journal-title":"J Clin Oncol"},{"key":"10128_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12032-024-02586-0","volume":"42","author":"M Lin","year":"2025","unstructured":"Lin M, Mo Y, Li CM, Liu YZ, Feng XP (2025) GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells. Med Oncol 42:49","journal-title":"Med Oncol"},{"key":"10128_CR47","doi-asserted-by":"publisher","first-page":"13939","DOI":"10.1074\/jbc.RA119.009091","volume":"294","author":"U Gopal","year":"2019","unstructured":"Gopal U, Mowery Y, Young K, Pizzo SV (2019) Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP\/TAZ protein signaling. J Biol Chem 294:13939\u201313952","journal-title":"J Biol Chem"},{"key":"10128_CR48","doi-asserted-by":"publisher","first-page":"e0188932","DOI":"10.1371\/journal.pone.0188932","volume":"12","author":"C Sun","year":"2017","unstructured":"Sun C, Han C, Jiang Y et al (2017) Inhibition of GRP78 abrogates radioresistance in oropharyngeal carcinoma cells after EGFR inhibition by cetuximab. PLoS ONE 12:e0188932","journal-title":"PLoS ONE"},{"key":"10128_CR49","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1158\/1078-0432.CCR-16-1935","volume":"23","author":"DYA Dadey","year":"2017","unstructured":"Dadey DYA, Kapoor V, Hoye K et al (2017) Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non-Small Cell Lung Cancer Cell Lines and Tumor Models. Clin Cancer Res 23:2556\u20132564","journal-title":"Clin Cancer Res"},{"key":"10128_CR50","doi-asserted-by":"publisher","first-page":"608911","DOI":"10.3389\/fonc.2020.608911","volume":"10","author":"K Liu","year":"2020","unstructured":"Liu K, Tsung K, Attenello FJ (2020) Characterizing Cell Stress and GRP78 in Glioma to Enhance Tumor Treatment. Front Oncol 10:608911","journal-title":"Front Oncol"},{"key":"10128_CR51","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.7150\/ijbs.69934","volume":"18","author":"J Jiang","year":"2022","unstructured":"Jiang J, Tang Q, Gong J et al (2022) Radiosensitizer EXO-miR-197-3p Inhibits Nasopharyngeal Carcinoma Progression and Radioresistance by Regulating the AKT\/mTOR Axis and HSPA5-mediated Autophagy. Int J Biol Sci 18:1878\u20131895","journal-title":"Int J Biol Sci"},{"key":"10128_CR52","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41419-025-07773-z","volume":"16","author":"F Ju","year":"2025","unstructured":"Ju F, Weng J, Fan N et al (2025) AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5. Cell Death Dis 16:483","journal-title":"Cell Death Dis"},{"key":"10128_CR53","doi-asserted-by":"crossref","unstructured":"Chien CY, Chen YC, Hsu CC et al (2021) YAP-dependent BiP induction is involved in nicotine-mediated oral cancer malignancy. Cells 10(8):2080","DOI":"10.3390\/cells10082080"},{"key":"10128_CR54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41419-020-2537-6","volume":"11","author":"J Song","year":"2020","unstructured":"Song J, Liu W, Wang J et al (2020) GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78. Cell Death Dis 11:352","journal-title":"Cell Death Dis"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10128-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10128-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10128-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:03:48Z","timestamp":1781053428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10128-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10128"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10128-9","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that they are not aware of any financial or personal relationships that might have been perceived as influencing the work presented in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}